vTv Therapeutics Inc.

NASDAQ: VTVT · Real-Time Price · USD
15.46
1.43 (10.19%)
At close: Aug 15, 2025, 3:58 PM
15.73
1.75%
After-hours: Aug 15, 2025, 04:10 PM EDT

vTv Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
36.75M 9.45M 12.13M 13.41M
Short-Term Investments
85K 65K 15K 100K
Long-Term Investments
n/a n/a 5.59M 9.17M
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
62K 102K 12.42M 57K
Inventory
n/a n/a 15K 100K
Other Current Assets
n/a n/a n/a 35K
Total Current Assets
38.11M 10.66M 27.09M 15.62M
Property-Plant & Equipment
153K 361K 556K 680K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
153K 361K 6.14M 9.85M
Total Assets
38.27M 11.02M 33.24M 25.47M
Account Payables
939K 4.08M 2.46M 1.88M
Deferred Revenue
n/a 17K 17K 35K
Short-Term Debt
169K 191K 224K 256K
Other Current Liabilities
-169K 4.7M 4.06M 3.2M
Total Current Liabilities
5.2M 10.62M 7.71M 8.5M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
100K 110K 684K 1.26M
Total Long-Term Liabilities
18.77M 18.95M 19.69M 1.75M
Total Liabilities
23.96M 29.57M 27.4M 10.25M
Total Debt
169K 529K 716K 932K
Common Stock
32K 27K 27K 901K
Retained Earnings
-299.72M -281.04M -265.52M -248.83M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
12.2M -24.68M -10.74M -9.74M
Total Investments
85K 65K 5.59M 9.17M